BNP Paribas Financial Markets’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,062
| Closed | -$271K | – | 3500 |
|
|
2020
Q4 | $271K | Sell |
2,062
-510
| -20% | -$67.1K | ﹤0.01% | 2112 |
|
|
2020
Q3 | $130K | Buy |
2,572
+2,153
| +514% | +$109K | ﹤0.01% | 2371 |
|
|
2020
Q2 | $20K | Sell |
419
-3,072
| -88% | -$146K | ﹤0.01% | 2769 |
|
|
2020
Q1 | $171K | Buy |
3,491
+2,170
| +164% | +$106K | ﹤0.01% | 2348 |
|
|
2019
Q4 | $75.8K | Sell |
1,321
-634
| -32% | -$36.4K | ﹤0.01% | 2769 |
|
|
2019
Q3 | $70.3K | Buy |
1,955
+114
| +6% | +$4.1K | ﹤0.01% | 2685 |
|
|
2019
Q2 | $57.2K | Sell |
1,841
-1,569
| -46% | -$48.8K | ﹤0.01% | 2727 |
|
|
2019
Q1 | $80K | Buy |
+3,410
| New | +$80K | ﹤0.01% | 2673 |
|